Conventional and high-dose daunorubicin and idarubicin in acute myeloid leukaemia remission induction treatment: a mixed treatment comparison meta-analysis of 7258 patients-Reference-Cited by-同舟云学术

Conventional and high-dose daunorubicin and idarubicin in acute myeloid leukaemia remission induction treatment: a mixed treatment comparison meta-analysis of 7258 patients

Published:2014-11-03 Issue:4 Volume:33 Page:212-219
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol Oncol

Author:

Sekine Leo¹²,Morais Vinícius Daudt¹,Lima Karine Margarites¹²,Onsten Tor Gunnar Hugo³,Ziegelmann Patrícia Klarmann¹⁴⁵,Ribeiro Rodrigo Antonini¹⁵²

Affiliation:

1. Post-Graduate Program in Epidemiology; Universidade Federal do Rio Grande do Sul; Porto Alegre Brazil

2. Institute for Research and Education, Hospital Moinhos de Vento; Porto Alegre Brazil

3. Internal Medicine Department, School of Medicine; Universidade Federal do Rio Grande do Sul; Porto Alegre Brazil

4. Statistics Department; Universidade Federal do Rio Grande do Sul; Porto Alegre Brazil

5. National Institute of Science and Technology for Health Technology Assessment, CNPq; Porto Alegre Brazil

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference37 articles.

1. A network meta-analysis of randomized controlled trials of induction treatments in acute myeloid leukemia in the elderly;Ziogas;Clin Ther,2011

2. Role of anthracyclines in the era of targeted therapy;Cortes-Funes;Cardiovasc Toxicol,2007

3. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity;Minotti;Pharmacol Rev,2004

4. The anthracyclines: when good things go bad;Minotti;Cardiovasc Toxicol,2007

5. The treatment of acute leukemia: past, present, and future;Beutler;Leukemia,2001

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How comparable are patient outcomes in the “real-world” with populations studied in pivotal AML trials?;Blood Cancer Journal;2024-03-26

2. Network medicine approaches for identification of novel prognostic systems biomarkers and drug candidates for papillary thyroid carcinoma;Journal of Cellular and Molecular Medicine;2023-10-19

3. Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience;Haematologica;2022-06-23

4. Influence of different intraradicular chemical pretreatments on the bond strength of adhesive interface between dentine and fiber post cements: A systematic review and network meta‐analysis;European Journal of Oral Sciences;2022-06-07

5. Evaluation of Tooth Sensitivity of In-office Bleaching with Different Light Activation Sources: A Systematic Review and a Network Meta-analysis;Operative Dentistry;2021-09-01